phone

Insulin Pumps - Medical Devices Pipeline Assessment, 2017

  • Published Date: 01 Aug 2017
  • Number of Pages: 162
  • Category: Healthcare and Medical
  • Country: Global
Insulin Pumps - Medical Devices Pipeline Assessment, 2017

Summary

GlobalDatas Medical Devices sector report, Insulin Pumps - Medical Devices Pipeline Assessment, 2017" provides an overview of Insulin Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalDatas team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Insulin Pumps under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Insulin Pumps and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Insulin Pumps under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the products current stage of development, territory and estimated launch date
Publisher Name : GlobalData

2 Introduction 8
2.1 Insulin Pumps Overview 8
3 Products under Development 9
3.1 Insulin Pumps - Pipeline Products by Stage of Development 9
3.2 Insulin Pumps - Pipeline Products by Segment 10
3.3 Insulin Pumps - Pipeline Products by Territory 11
3.4 Insulin Pumps - Pipeline Products by Regulatory Path 12
3.5 Insulin Pumps - Pipeline Products by Estimated Approval Date 13
3.6 Insulin Pumps - Ongoing Clinical Trials 14
4 Insulin Pumps - Pipeline Products under Development by Companies 15
4.1 Insulin Pumps Companies - Pipeline Products by Stage of Development 15
4.2 Insulin Pumps - Pipeline Products by Stage of Development 16
5 Insulin Pumps Companies and Product Overview 17
5.1 Amrita Vishwa Vidyapeetham Company Overview 17
5.1.1 Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Andain, Inc Company Overview 18
5.2.1 Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Cellnovo Ltd Company Overview 20
5.3.1 Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 Debiotech SA Company Overview 22
5.4.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 22
5.5 Hospira Inc Company Overview 26
5.5.1 Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 26
5.6 Insulet Corp Company Overview 27
5.6.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.7 LifeScan Inc Company Overview 32
5.7.1 LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 32
5.8 MedSolve Technologies, Inc. Company Overview 33
5.8.1 MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
5.9 MicroPort Scientific Corp Company Overview 34
5.9.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 34
5.10 NanoMed Ltd Company Overview 36
5.10.1 NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.11 Phluid Corporation Company Overview 37
5.11.1 Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
5.12 Sensile Medical AG Company Overview 38
5.12.1 Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 38
5.13 SFC Fluidics LLC Company Overview 39
5.13.1 SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 39
5.14 Spring Health Solutions Ltd. Company Overview 40
5.14.1 Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
5.15 Tandem Diabetes Care Inc Company Overview 41
5.15.1 Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.16 Terumo Corp Company Overview 47
5.16.1 Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 47
5.17 ViCentra BV Company Overview 48
5.17.1 ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 48
5.18 Ypsomed Holding AG Company Overview 49
5.18.1 Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 49
6 Insulin Pumps- Recent Developments 50
6.1 Jul 24, 2017: MicroPort Attends EUROPACE-CARDIOSTIM 2017 50
6.2 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 50
6.3 Jul 17, 2017: Integer Announces Appointment of Joseph W. Dziedzic as President and Chief Executive Officer 52
6.4 Jul 07, 2017: MPSC New COO Glendy Wang on Board 53
6.5 Jun 21, 2017: ConvaTec Group: Board appointment 53
6.6 Jun 21, 2017: Eli Lilly And Company Unveils Expanded Biotechnology Center In San Diego 54
6.7 Jun 13, 2017: Capillary Biomedical Sheds Light on the Mechanical Challenges of Insulin Pump Delivery Systems at Annual ADA Scientific Sessions 55
6.8 Jun 12, 2017: Tandem Diabetes Care Presents Findings from Predictive Low Glucose Suspend (PLGS) Feasibility Study and Announces Approval of Investigational Device Exemption (IDE) for Pivotal Trial 56
6.9 Jun 06, 2017: Medtronic Announces Scientific Data Presentations at the American Diabetes Association 77th Meeting 56
6.10 Jun 01, 2017: Derica Rice To Retire As Lilly Chief Financial Officer 58
6.11 May 30, 2017: Insulet Appoints Bret Christensen as Chief Commercial Officer 58
6.12 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 59
6.13 May 24, 2017: Ypsomed accelerates growth significantly 62
6.14 May 23, 2017: MicroPort Listed as Enterprises Conforming to CSR Standards for Six Consecutive Years 64
6.15 May 10, 2017: Leigh Ann Pusey Joins Lilly as Senior Vice President of Corporate Affairs and Communications 64
6.16 May 10, 2017: Ypsomed expands to more countries 65
6.17 May 08, 2017: Insulet Reports First Quarter 2017 Financial Results 65
6.18 May 08, 2017: Integer Holdings Reports First Quarter 2017 Results 66
6.19 May 04, 2017: ConvaTec Group: Trading Update for the three months ended 31 March 2017 67
6.20 May 02, 2017: DexCom Reports First Quarter 2017 Financial Results 69
6.21 Apr 27, 2017: Roche reports a good start in 2017 69
6.22 Apr 27, 2017: Tandem Diabetes Care Reports First Quarter 2017 Financial Results 71
6.23 Apr 26, 2017: Cellnovo announces its Full Year 2016 Results and Q1 2017 Sales 72
6.24 Apr 25, 2017: Lilly Reports First-Quarter 2017 Results 74
6.25 Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 79
6.26 Apr 12, 2017: Unilife Files for Chapter 11 Protection 81
6.27 Apr 05, 2017: Kaleido wins at the Transform Awards Europe 2017 82
6.28 Apr 04, 2017: Lilly and Ohio University Heritage College of Osteopathic Medicine Partner on Rotation Program for Medical Students 83
6.29 Apr 03, 2017: Cellnovo Appoints Erwan Martin as Chief Financial Officer 84
6.30 Mar 30, 2017: ConvaTec Expands Unomedical Manufacturing Technology Partnership with Medtronic Diabetes to Meet Growing Demand 84
6.31 Mar 30, 2017: MPSC Announces 2016 Annual Results 85
6.32 Mar 29, 2017: ConvaTec Group: Directorate changes 87
6.33 Mar 28, 2017: ConvaTec: Proposed Directorate Changes 87
6.34 Mar 27, 2017: Integer Announces Leadership Change 88
6.35 Mar 13, 2017: DexCom Appoints Richard Collins to Board of Directors 88
6.36 Mar 08, 2017: Tandem Diabetes Care Reports 2016 Financial Results 89
6.37 Mar 07, 2017: ViCentra Announces New Chairman of the Board 91
6.38 Mar 02, 2017: Lilly Announces Changes In Senior Management 92
6.39 Feb 28, 2017: DexCom Reports Fourth Quarter and Fiscal Year 2016 Financial Results 93
6.40 Feb 27, 2017: Insulet Reports Fourth Quarter and Full Year 2016 Financial Results 93
6.41 Feb 27, 2017: Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer 95
6.42 Feb 27, 2017: Integer Holdings Reports Results for Fourth Quarter and Full Year 2016 95
6.43 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 98
6.44 Feb 16, 2017: Sensile Medical Strengthens Executive Team for Future Growth 101
6.45 Feb 09, 2017: Carolyn R. Bertozzi, Ph.D., Elected To Lilly Board Of Directors 102
6.46 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 103
6.47 Feb 01, 2017: Roche reports good results in 2016 103
6.48 Jan 31, 2017: Lilly Reports Fourth-Quarter And Full-Year 2016 Results 106
6.49 Jan 31, 2017: Cellnovo: 2016 Full-Year Sales 113
6.50 Jan 25, 2017: Ypsomed opens a new production line in Solothurn 113
6.51 Jan 10, 2017: DexCom Reports Record Preliminary, Unaudited Revenue for the Fourth Quarter and Fiscal Year 2016 and Provides Initial 2017 Outlook 114
6.52 Jan 05, 2017: Lilly To Adjust Organization And Leadership Structure To Better Align With Growth Opportunities 114
6.53 Dec 28, 2016: MicroPort was selected as a pilot project of Patent Alliance of Enterprises in Shanghai Zhangjiang National Innovation Demonstration Zone 116
6.54 Dec 20, 2016: OneTouch Vibe Plus Insulin Pump Earns FDA Approval and Health Canada License and is First Pump Integrated with the Dexcom G5 Mobile Continuous Glucose Monitor 116
6.55 Dec 15, 2016: Lilly Provides 2017 Financial Guidance And 2016 Update, Reaffirms Financial Expectations Through The Remainder Of The Decade 117
6.56 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 118
6.57 Nov 16, 2016: Cellnovo Files for 510(k) Approval with the FDA for Its Mobile, Connected, All-in-One Diabetes Management System 121
6.58 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 122
6.59 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 122
6.60 Nov 14, 2016: Diabetes Management Leader Dexcom Expands Presence in EMEA Markets with new Edinburgh HQ 123
6.61 Nov 03, 2016: Insulet Reports Third Quarter 2016 Financial Results 124
6.62 Nov 03, 2016: Ypsomed continues on its path of growth 125
6.63 Nov 02, 2016: Unilife Provides Business Update 126
6.64 Nov 01, 2016: DexCom Reports Third Quarter 2016 Financial Results 127
6.65 Nov 01, 2016: Tandem Diabetes Care Reports Third Quarter 2016 Financial Results 128
6.66 Oct 25, 2016: Lilly Reports Third-Quarter 2016 Results 130
6.67 Oct 24, 2016: Tandem Diabetes Care Now Shipping Next-Generation t:slim X2 Insulin Pump 135
6.68 Oct 24, 2016: Unilife Announces Filing of 2016 10-K 135
6.69 Oct 24, 2016: Unilife Announces Fiscal Year 2016 Finanicial Results 137
6.70 Oct 20, 2016: Roche delivers good sales growth in the first nine months of 2016 138
6.71 Oct 19, 2016: Abbott Reports Third-Quarter 2016 Results 141
6.72 Oct 19, 2016: Insulet Announces Board and Management Changes 144
6.73 Oct 04, 2016: Tandem Diabetes Care Now Taking Orders for Next-Generation t:slim X2 Insulin Pump 144
6.74 Sep 29, 2016: Unilife Provides Trading Update 145
6.75 Sep 27, 2016: New member joins Executive Management in the Ypsomed Group 146
6.76 Sep 27, 2016: MicroPort Hosts First EMEA Regional Distributor Summit 146
6.77 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 146
6.78 Sep 14, 2016: Levi Garraway, M.D., Ph.D., to become Senior Vice President of Global Oncology at Lilly, Succeeding Richard Gaynor, M.D., Who is Retiring after a Distinguished Career 147
6.79 Sep 06, 2016: Insulet to Establish Highly-Automated Manufacturing Operation in the United States 148
6.80 Sep 06, 2016: ViCentra Appoints Two New Medical and Scientific Advisors 148
6.81 Sep 06, 2016: Insulet Announces Executive Appointments 149
6.82 Sep 05, 2016: Manufacturer of Accu-Chek Insight insulin pumps issues updated handling instructions following user feedback 150
6.83 Aug 31, 2016: Jamere Jackson Elected To Lilly Board Of Directors 151
6.84 Aug 30, 2016: MPSC Announces 2016 Interim Results 151
6.85 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 153
6.86 Aug 10, 2016: Lilly announces Joshua Smiley, Anat Ashkenazi appointed to new roles, Thomas Grein retires 155
6.87 Aug 03, 2016: Insulet Reports Second Quarter 2016 Financial Results 156
6.88 Aug 02, 2016: DexCom Reports Second Quarter 2016 Financial Results 157
7 Appendix 159
7.1 Methodology 159
7.2 About GlobalData 162
7.3 Contact Us 162
7.4 Disclaimer 162

List Of Tables


Table 1: Insulin Pumps - Pipeline Products by Stage of Development 9
Table 2: Insulin Pumps - Pipeline Products by Segment 10
Table 3: Insulin Pumps - Pipeline Products by Territory 11
Table 4: Insulin Pumps - Pipeline Products by Regulatory Path 12
Table 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13
Table 6: Insulin Pumps - Ongoing Clinical Trials 14
Table 7: Insulin Pumps Companies - Pipeline Products by Stage of Development 15
Table 8: Insulin Pumps - Pipeline Products by Stage of Development 16
Table 9: Amrita Vishwa Vidyapeetham Pipeline Products & Ongoing Clinical Trials Overview 17
Table 10: Amrita Insulin Pump - Product Status 17
Table 11: Amrita Insulin Pump - Product Description 17
Table 12: Andain, Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 13: Gaia Med Diamond Semi-Disposable Pump - Product Status 18
Table 14: Gaia Med Diamond Semi-Disposable Pump - Product Description 18
Table 15: Gemini Pump - Product Status 19
Table 16: Gemini Pump - Product Description 19
Table 17: Cellnovo Ltd Pipeline Products & Ongoing Clinical Trials Overview 20
Table 18: Cellnovo Wireless Insulin Pump System - Product Status 20
Table 19: Cellnovo Wireless Insulin Pump System - Product Description 21
Table 20: Wireless Insulin Pump System Integrated With inControl AP - Product Status 21
Table 21: Wireless Insulin Pump System Integrated With inControl AP - Product Description 21
Table 22: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 22
Table 23: Jewel Pump - Product Status 22
Table 24: Jewel Pump - Product Description 23
Table 25: JewelPUMP2 - Product Status 23
Table 26: JewelPUMP2 - Product Description 24
Table 27: Nanopump - Product Status 24
Table 28: Nanopump - Product Description 25
Table 29: Hospira Inc Pipeline Products & Ongoing Clinical Trials Overview 26
Table 30: Integrated Symbiq/EndoTool System - Product Status 26
Table 31: Integrated Symbiq/EndoTool System - Product Description 26
Table 32: Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 27
Table 33: OmniPod - Humalog U200 - Product Status 27
Table 34: OmniPod - Humalog U200 - Product Description 28
Table 35: OmniPod - New Version - Product Status 28
Table 36: OmniPod - New Version - Product Description 28
Table 37: Omnipod Dash Insulin Management System - Product Status 29
Table 38: Omnipod Dash Insulin Management System - Product Description 29
Table 39: Insulet Corp - Ongoing Clinical Trials Overview 30
Table 40: Omnipod Dash Insulin Management System - Evaluating Glucose Control in Patients with Type 1 Diabetes Under Free-living Conditions with the Insulet Automated Glucose Control System: IDE3 31
Table 41: LifeScan Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 42: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Status 32
Table 43: ONETOUCH Ping Verio Insulin Pump With Meter Remote - Product Description 32
Table 44: MedSolve Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 33
Table 45: Freehand Patch Pump - Product Status 33
Table 46: Freehand Patch Pump - Product Description 33
Table 47: MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 34
Table 48: Angel Touch - Product Status 34
Table 49: Angel Touch - Product Description 34
Table 50: La Fenice V - Product Status 35
Table 51: La Fenice V - Product Description 35
Table 52: NanoMed Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
Table 53: FMA Patch - Diabetes Mellitus - Product Status 36
Table 54: FMA Patch - Diabetes Mellitus - Product Description 36
Table 55: Phluid Corporation Pipeline Products & Ongoing Clinical Trials Overview 37
Table 56: Ambulatory Diabetes Pump - Product Status 37
Table 57: Ambulatory Diabetes Pump - Product Description 37
Table 58: Sensile Medical AG Pipeline Products & Ongoing Clinical Trials Overview 38
Table 59: Bolus Patch - Product Status 38
Table 60: Bolus Patch - Product Description 38
Table 61: SFC Fluidics LLC Pipeline Products & Ongoing Clinical Trials Overview 39
Table 62: Disposable Insulin Patch Pump - Product Status 39
Table 63: Disposable Insulin Patch Pump - Product Description 39
Table 64: Spring Health Solutions Ltd. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 65: Spring Zone Hybrid Patch Pump - Product Status 40
Table 66: Spring Zone Hybrid Patch Pump - Product Description 40
Table 67: Tandem Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 68: Next-Generation t:slim X2 Insulin Pump - Pediatric - Product Status 41
Table 69: Next-Generation t:slim X2 Insulin Pump - Pediatric - Product Description 42
Table 70: t:slim X2 Pump With Predictive Low Glucose Suspend Algorithm - Product Status 42
Table 71: t:slim X2 Pump With Predictive Low Glucose Suspend Algorithm - Product Description 43
Table 72: Tandem Diabetes Care Inc - Ongoing Clinical Trials Overview 44
Table 73: t:slim X2 Pump With Predictive Low Glucose Suspend Algorithm - Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes 45
Table 74: Next-Generation t:slim X2 Insulin Pump - Pediatric - Tandem PLGS Pivotal Trial: A Randomized Clinical Trial to Assess the Efficacy of Predictive Low Glucose Suspend Versus Sensor-augmented Pump Therapy in the Management of Type 1 Diabetes 46
Table 75: Terumo Corp Pipeline Products & Ongoing Clinical Trials Overview 47
Table 76: Insulin Pump - Product Status 47
Table 77: Insulin Pump - Product Description 47
Table 78: ViCentra BV Pipeline Products & Ongoing Clinical Trials Overview 48
Table 79: Kaleido Insulin Pump - Product Status 48
Table 80: Kaleido Insulin Pump - Product Description 48
Table 81: Ypsomed Holding AG Pipeline Products & Ongoing Clinical Trials Overview 49
Table 82: Lanzi - Product Status 49
Table 83: Lanzi - Product Description 49
Table 84: Glossary 161

List Of Figures


Figure 1: Insulin Pumps - Pipeline Products by Stage of Development 9
Figure 2: Insulin Pumps - Pipeline Products by Segment 10
Figure 3: Insulin Pumps - Pipeline Products by Territory 11
Figure 4: Insulin Pumps - Pipeline Products by Regulatory Path 12
Figure 5: Insulin Pumps - Pipeline Products by Estimated Approval Date 13
Figure 6: Insulin Pumps - Ongoing Clinical Trials 14

Insulin Pumps - Medical Devices Pipeline Assessment, 2017 GlobalDatas Medical Devices sector report, Insulin Pumps - Medical Devices Pipeline Assessment, 2017 provides an overview of Insulin Pumps currently in pipeline stage. The

View Report

The global insulin pens, syringes, pumps and injectors market was estimated to be around $7.7 billion as of 2016. The global insulin pens, syringes, pumps and injectors made up around

View Report

Insulin Resistance - Pipeline Review, H2 2017 Global Markets Directs latest Pharmaceutical and Healthcare disease pipeline guide Insulin Resistance - Pipeline Review, H2 2017, provides an overview of the Insulin Resistance

View Report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports